Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001571049-17-006835
Filing Date
2017-07-20
Accepted
2017-07-20 16:05:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS t1702139-424b4.htm 424B4 566009
2 GRAPHIC lg_cyclacel-withregmark.jpg GRAPHIC 124046
  Complete submission text file 0001571049-17-006835.txt   738119
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-218305 | Film No.: 17974409
SIC: 2834 Pharmaceutical Preparations